Innate immune defenses mediated by two ilc subsets are critical for protection against acute clostridium difficile infection

Cell Host and Microbe

Volumn 18, Issue 1, 2015, Pages 27-37

  Abt, Michael C ^a   Lewis, Brittany B ^a   Caballero, Silvia ^a   Xiong, Huizhong ^a   Carter, Rebecca A ^a   Susac, Boze ^a   Ling, Lilan ^a   Leiner, Ingrid ^a   Pamer, Eric G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; ILC1 ASSOCIATED PROTEIN; ILC3 ASSOCIATED PROTEIN; INTERLEUKIN 22; PROTEIN; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; HOST RESISTANCE; INFECTION RESISTANCE; INFECTION SENSITIVITY; INNATE IMMUNITY; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; C57BL MOUSE; CLOSTRIDIUM INFECTION; DISEASE RESISTANCE; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE SUBPOPULATION; PEPTOCLOSTRIDIUM DIFFICILE; SURVIVAL ANALYSIS;

ANIMALS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DISEASE RESISTANCE; IMMUNITY, INNATE; LYMPHOCYTE SUBSETS; MICE, INBRED C57BL; MICE, KNOCKOUT; SURVIVAL ANALYSIS;

EID: 84943170553     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2015.06.011     Document Type: Article

References (59)

1. Artis, D., and Spits, H. (2015). The biology of innate lymphoid cells. Nature 517, 293-301.
2. Bernink J.H.,Peters C.P.,Munneke M.,te Velde, A.A., Me ijer, S.L., Weijer, K., Hreggvidsdottir, H.S., Heinsbroek, S.E., Legrand, N., Buskens, C.J., et al. 2013 Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat. Immunol. 14 221-229.
3. Boyman, O., Ramsey, C., Kim, D.M., Sprent, J., and Surh, C.D. (2008). IL-7/anti-IL-7 mAb complexes restore T cell development and induce homeostatic T Cell expansion without lymphopenia. J. Immunol. 180, 7265-7275.
4. Buffie, C.G., Jarchum, I., Equinda, M., Lipuma, L., Gobourne, A., Viale, A., Ubeda, C., Xavier, J., and Pamer, E.G. (2012). Profound alterations of intestinal microbiota following a single dose of clindamycin result s in sustained susceptibility to Clostridium difficile-induced colitis. Infect. Immun. 80, 62-73.
5. Buffie, C.G., Bucci, V., Stein, R.R., McKenney, P.T., Ling, L., Gobourne, A., No, D., Liu, H., Kin nebrew, M., Viale, A., et al. (2015). Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517, 205-208.
6. Buonomo, E.L., Madan, R., Pramoonjago, P., Li, L., Okusa, M.D., and Petri, W.A., Jr. (2013). Role of interleukin 23 signaling in Clostridium difficile colitis. J. Infect. Dis. 208, 917-920.
7. Chen, X., Katchar, K., Goldsmith, J.D., Nanthakumar, N., Cheknis, A., Gerding, D.N., and Kelly, C.P. (2008). A mouse model of Clostridium difficile-Associated disease. Gastroenterology 135, 1984-1992.
8. Chopra, T., Alangaden, G.J., and Chandraseka r, P. (2010). Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients. Expert Rev. Anti Infect. Ther. 8, 1113-1119.
9. Chovatiya, R., and Medzhitov, R. (2014). Stress, infl ammation, and defense of homeostasis. Mol. Cell 54, 281-288.
10. Diefenbach, A. (2013). Innate lymphoid cells in the defense against infections. Eur J Microbiol Immunol (Bp) 3, 143-151.
11. Dubberke, E.R., Reske, K.A., Srivastava, A., Sadhu, J., Gatti, R., Young, R.M., Rakes, L.C., Dieckgraefe, B., DiPersio, J., and Fraser, V.J. (2010). Clostridium difficile-Associated disease in allogeneic he matopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomes. Clin. Transplant. 24, 192-198.
12. Eberl, G., and Littman, D.R. (2004). Thymic origin of intestinal alphabeta T cells revealed by fate mapping of RORgammat+ cells. Science 305, 248-251.
13. Eberl, G., Marmon, S., Sunshine, M.J., Rennert, P.D., Choi, Y., and Littman, D.R. (2004). An essential function for the nucl ear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 5, 64-73.
14. Fuchs, A., Vermi, W., Lee, J.S., Lonardi, S., Gilfillan, S., Newberry, R.D., Cella, M., and C olonna, M. (2013). Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12-And IL-15-responsive IFN-g-producing cells. Immunity 38, 769-781.
15. Garrett, W.S., Lord, G.M., Punit, S., Lugo-Villarino, G., Mazmanian, S.K., Ito, S., Glickman, J.N., and Glimcher, L.H. (2007). Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131, 33-45.
16. Geiger, T.L., Abt, M.C., Gasteiger, G., Firth, M.A., O'Connor, M.H., Geary, C.D., O'Sullivan, T.E., van den Brink, M.R., Pamer, E.G., Hanash, A.M., and Sun, J.C. (2014). Nfil3 is crucial for development of innate lymphoid cells and host protection against intestinal pathogens. J. Exp. Med. 211, 1723-1731.
17. Gladiator, A., Wangler, N., Trautwein-Weidner, K., and LeibundGut-Landmann, S. (2013). Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection. J. Immunol. 190, 521-525.
18. Gordon, S.M., Chaix, J., Rupp, L.J., Wu, J., Madera, S., Sun, J.C., Lindsten, T., and Reiner, S.L. (2012). The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 36, 55-67.
19. Hasegawa, M., Yamazaki, T., Kamada, N., Tawaratsumida, K., Kim, Y.G., Núñez, G., and Inohara, N. (2011). Nucleotide-binding oligomerization domain 1 mediates recognition of Clostridium difficile and induces neutrophil recruitment and protection against the pathogen. J. Immunol. 186, 487 2-4880.
20. Hasegawa, M., Kamada, N., Jiao, Y., Liu, M.Z., Núñez, G., and Inohara, N. (2012). Protective role of commensals against Clostridium difficile infection via an IL-1b-mediated positive-feedback loop. J. Immunol. 189, 3085-3091.
21. Hasegawa, M., Yada, S., Liu, M.Z., Kamada, N., Muñoz-Planillo, R., Do, N., Núñez, G., and Inohara, N. (2014). Interleukin-22 regulates the complement system to promote resistance against pathobionts after pathogen-induced intestinal damage. Immunity 41, 620-632.
22. Huang, H., Weintraub, A., Fang, H., and Nord, C.E. (2009). Antimicrobial resistance in Clostridium difficile. Int. J. Antimicrob. Agents 34, 516-522.
23. Hunt J.J.,Ballard, J.D. 2013 Variations in virulence and molecular biology among emerging strains of Clostridium difficile. Microbiol. Mol. Biol. Rev. 77 567-581.
24. Jarchum, I., Liu, M., Lipuma, L., and Pamer, E.G. (2011). Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis. Infect. Immun. 79, 1498-1503.
25. Jarchum, I., Liu, M., Shi, C., Equinda, M., and Pamer, E.G. (2012). Critical role for MyD88-mediated neutrophil recruitment during Clostridium difficile colitis. Infect. Immun. 80, 2989-2996.
26. Johnson, S. (2009). Recurrent C lostridium difficile infection: a review of risk factors, treatments, and outcomes. J. Infect. 58, 403-410.
27. Just, I., Selzer, J., Wilm, M., von Eichel-Streiber, C., Mann, M., and Aktories, K. (1995). Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375, 500-503.
28. Kinnebrew, M.A., Buffie, C.G., Diehl, G.E., Zenewicz, L.A., Leiner, I., Hohl, T.M., Flavell, R.A., Littman, D.R., and Pamer, E.G. (2012). Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense. Immunity 36, 276-287.
29. Klose, C.S ., Kiss, E.A., Schwierzeck, V., Ebert, K., Hoyler, T., d'Hargues, Y., Göppert, N., Croxford, A.L., Waisman, A., Tanriver, Y., and Diefenbach, A. (2013). A T-bet gradient controls the fate and function of CCR6-RORgt+ innate lymph oid cells. Nature 494, 261-265.
30. Klose, C.S., Flach, M., Mohle, L., Rogell, L., Hoyler, T., Ebert, K., Fabiunke, C., Pfeifer, D., Sexl, V., Fonseca-Pereira, D., et al. (2014). Differentiation of type 1 ILCs f rom a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157, 340-356.
31. Kraaij, M.D., Vereyken, E.J., Leenen, P.J., van den Bosch, T.P., Rezaee, F., Betjes, M.G., Baan, C.C., and Rowshani, A.T. (2014). Human monocytes produce interferon-gamma upon stimulation with LPS. Cytokine 67, 7-12.
32. Kyne, L., Warny, M., Qamar, A., and Kelly, C.P. (2000). Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N. Engl. J. Med. 342, 390-397.
33. Kyne, L., Warny, M., Qamar, A., and Kelly, C.P. (2001). Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 357, 189-193.
34. Lawley, T.D., Clare, S., Walker, A.W., Goulding, D., Stabler, R.A., Croucher, N., Mastroeni, P., Scott, P., Raisen , C., Mottram, L., et al. (2009). Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, sporemediated transmission, and severe disease in immunocompromised hosts. Infect. Immun. 77, 3661-366 9.
35. Lawley, T.D., Clare, S., Walker, A.W., Stares, M.D., Connor, T.R., Raisen, C., Goulding, D., Rad, R., Schreiber, F., Brandt, C., et al. (2012). Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog. 8, e1002995.
36. Lewis, B.B., Buffie, C.G., Carter, R., Leiner, I., Toussaint, N.C., Miller, L., Gobourne, A., Ling, L., and Pamer, E. (2015). Loss of microbiota-mediated colonization resistance to Clostridium difficile infection is greater following oral vancomycin as compared with metronidazole. J. Infect. Dis. Published online April 28, 2015. http://dx.doi.org/10.1093/infdis/jiv256.
37. Lucado, J., Gould, C., and Elixhauser, A. (2012). Clostridium Difficile Infections (CDI) in Hospital Stays, 2009: Statistical Brief #124. In Healthcare Cost and Utilization Project (HCUP) Statistical Briefs (Rockville, MD: Agency for Health Care Policy and Research (US)).
38. Lyras, D., O'Connor, J.R., Howarth, P.M., Sambol, S.P., Carter, G.P., Phumoonna, T., Poon, R., Adams, V., Vedantam, G., Johnson, S., et al. (2009). Toxin B is essential for virulence of Clostridium difficile. Nature 458, 1176-1179.
39. McDermott, A.J., Higdon, K.E., Muraglia, R., Erb-Downward, J.R., Falkowski, N.R., McDonald, R.A., Young, V.B., and Huffnagle, G.B. (2015). The role of Gr-1(+) cells and tumour necrosis factor-A signalling during Cl ostridium difficile colitis in mice. Immunology 144, 704-716.
40. Mundy, R., MacDonald, T.T., Dougan, G., Frankel, G., and Wiles, S. (2005). Citrobacter rodentium of mice and man. Cell. Microbiol. 7, 1697-1706.
41. Pepin, J., Alary, M.E., Valiquette, L., Raiche, E., Ruel, J., Fulop, K., Godin, D., and Bourassa, C. (2005). Increasing risk of relapse after treatment of Clostridium difficile colit is in Quebec, Canada. Clin. Infect. Dis. 40, 1591-1597.
42. Powell, N., Walker, A.W., Stolarczyk, E., Canavan, J.B., Gökmen, M.R., Marks, E., Jackson, I., Hashim, A., Curtis, M.A., Jenner, R.G., et al. (2012). The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells. Immunity 37, 674-684.
43. Rupnik, M., Wilcox, M.H., and Gerding, D.N. (2009). Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat. Rev. Microbiol. 7, 526-536.
44. Sadighi Akha, A.A., The riot, C.M., Erb-Downward, J.R., McDermott, A.J., Falkowski, N.R., Tyra, H.M., Rutkowski, D.T., Young, V.B., and Huffnagle, G.B. (2013). Acute infection of mice with Clostridium difficile leads to eIF2a phosphorylation and p ro-survival signalling as part of the mucosal inflammatory response. Immunology 140, 111-122.
45. Sadighi Akha, A.A., McDermott, A.J., Theriot, C.M., Carlson, P.E., Jr., Frank, C.R., McDonald, R.A., Falkowski, N.R., Bergin, I.L., Young, V.B., and Huffnagle, G.B. (2015). Interleukin-22 and CD160 play additive roles in the host mucosal response to Clostridium difficile infection in mice. Immunology 144, 587-597.
46. Satoh-Takayama N.,Vosshenrich C.A.,Lesjean-Pottier S.,Sawa S.,Lochner M.,Rattis F.,Mention J.J.,Thiam K.,Cerf-Bensussan N.,Mandelboim O.,et al. 2008 Microbial flora drives interle ukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense Immunity 29 958-970.
47. Seekatz, A.M., Aas, J., Gessert, C.E., Rubin, T.A., Saman, D.M., Bakken, J.S., and Young, V.B. (2014). Recovery of the gut microbiome following fecal microbiota transplantation. MBio 5, e00893-e14.
48. Sonnenberg, G.F., Monticelli, L.A., Elloso, M.M., Fouser, L.A., and Artis, D. (2011). CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 34, 122-134.
49. Sonnenberg, G.F., Mjösberg, J., Spits, H., and Artis, D. (2013). SnapShot: innate lymphoid cells. Immunity 39, 622, e1.
50. Spees, A.M., Kingsbury, D.D., Wangdi, T., Xavier, M.N., Tsolis, R.M., and Baümler, A.J. (2014). Neutrophils are a source of gamma interferon during acute Salmonella enterica serovar Typhimurium coli tis. Infect. Immun. 82, 1692-1697.
51. Tu, T.C., Brown, N.K., Kim, T.J., Wroblewska, J., Yang, X., Guo, X., Lee, S.H., Kumar, V., Lee, K.M., and Fu, Y.X. (2015). CD160 is essential for NK-mediated IFN-g production. J. Exp. Med. 212, 415-429.
52. Tvede, M., Tinggaard, M., and Helms, M. (2015). Rectal bacteriotherapy for recurrent Clostridium difficile-Associated diarrhoea: results from a case series of 55 pa tients in Denmark 2000-2012. Clin. Microbiol. Infect. 21, 48-53.
53. Ubeda, C., Lipuma, L., Gobourne, A., Viale, A., Leiner, I., Equinda, M., Khanin, R., and Pamer, E.G. (2012). Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice. J. Exp. Med. 209, 1445-1456.
54. Viswanathan, V.K., Mallozzi, M.J., and Vedantam, G. (2010). Clostr idium difficile infection: An overview of the disease and its pathogenesis, epidemiology and interventions. Gut Microbes 1, 234-242.
55. Voth, D.E., and Ballard, J.D. (2005). Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18, 247-263.
56. Warren, C.A., van Opstal, E., Ballard, T.E., Kennedy, A., Wang, X., Riggins, M., Olekhnovich, I., Warthan, M., Kolling, G.L., Guerrant, R.L., et al. (2012). Amixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, shows efficacy against Clostridium difficile in a mouse infection model. Antimicrob. Agents Chemother. 56, 4103-4111.
57. Wren, S.M., Ahmed, N., Jamal, A., and Safadi, B.Y. (2005). Preoperative oral antibiotics in colorectal surgery increase the rate of Clostridium difficile colitis. Arch. Surg. 140, 752-756.
58. Ye, P., Rodriguez, F.H., Kanaly, S., Stocking, K.L., Schurr, J., Schwarzenberger, P., Oliver, P., Huang, W., Zhang, P., Zhang, J., et al. (2001). Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte c olony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194, 519-527.
59. Zheng, Y., Valdez, P.A., Danilenko, D.M., Hu, Y., Sa, S.M., Gong, Q., Abbas, A.R., Modrusan, Z., Ghilardi, N., de Sauvage, F.J., and Ouyang, W. (2008). Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14, 282-289.